Winton Group LTD Adc Therapeutics Sa Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Jul 21, 2021	SELL	$22.75 - $34.05 $3.77 Million - $5.64 Million	-165,601 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$25.26 - $38.02 $1.62 Million - $2.44 Million	-64,100 Reduced 27.91%	165,601 $5.3 Million
Q3 2020 Oct 30, 2020	BUY	$32.87 - $51.05 $23,041 - $35,786	701 Added 0.31%	229,701 $2.6 Million
Q2 2020 Aug 05, 2020	BUY	$29.65 - $46.81 $6.79 Million - $10.7 Million	229,000 New	229,000 $10.7 Million

55.1M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $175M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.